Compare Stocks: CALC, FLNA, AGFY, and IXHL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGFY Agrify	$19.60 -2.0%	$22.03	$13.22 ▼ $48.84	$39.26M	9.96	31,892 shs	20,958 shs
CALC CalciMedica	$1.60 -3.0%	$2.63	$1.58 ▼ $36.00	$10.93M	0.76	67,026 shs	21,711 shs
FLNA Cassava Sciences	$0.93 -3.5%	$0.88	$0.67 ▼ $4.98	$44.97M	-0.65	5.67 million shs	1.68 million shs
IXHL Incannex Healthcare	$3.21 -1.2%	$3.31	$2.49 ▼ $15.00	$40.27M	6.97	90,270 shs	52,102 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGFY Agrify	-2.00%	-9.93%	-18.33%	-22.96%	-52.20%
CALC CalciMedica	0.00%	-8.57%	-27.27%	-66.85%	-89.54%
FLNA Cassava Sciences	0.00%	+24.44%	+12.39%	-24.32%	-70.91%
IXHL Incannex Healthcare	0.00%	-3.31%	-1.23%	-19.14%	-75.24%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGFY Agrify	$19.60 -2.0%	$22.03	$13.22 ▼ $48.84	$39.26M	9.96	31,892 shs	20,958 shs
CALC CalciMedica	$1.60 -3.0%	$2.63	$1.58 ▼ $36.00	$10.93M	0.76	67,026 shs	21,711 shs
FLNA Cassava Sciences	$0.93 -3.5%	$0.88	$0.67 ▼ $4.98	$44.97M	-0.65	5.67 million shs	1.68 million shs
IXHL Incannex Healthcare	$3.21 -1.2%	$3.31	$2.49 ▼ $15.00	$40.27M	6.97	90,270 shs	52,102 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGFY Agrify	-2.00%	-9.93%	-18.33%	-22.96%	-52.20%
CALC CalciMedica	0.00%	-8.57%	-27.27%	-66.85%	-89.54%
FLNA Cassava Sciences	0.00%	+24.44%	+12.39%	-24.32%	-70.91%
IXHL Incannex Healthcare	0.00%	-3.31%	-1.23%	-19.14%	-75.24%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGFY Agrify	0.00	N/A	N/A	N/A
CALC CalciMedica	2.20	Hold	$50.00	3,025.00% Upside
FLNA Cassava Sciences	2.00	Hold	$5.00	437.11% Upside
IXHL Incannex Healthcare	2.00	Hold	$18.00	460.75% Upside

Current Analyst Ratings Breakdown

Latest CALC, FLNA, AGFY, and IXHL Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/22/2026	FLNA Cassava Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/27/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	CALC CalciMedica	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
8/13/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/13/2026	CALC CalciMedica	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/29/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/29/2026	CALC CalciMedica	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/20/2026	FLNA Cassava Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	IXHL Incannex Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/7/2026	CALC CalciMedica	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGFY Agrify	$12.26M	3.20	N/A	N/A	$10.47 per share	1.87
CALC CalciMedica	N/A	N/A	N/A	N/A	($2.30) per share	N/A
FLNA Cassava Sciences	N/A	N/A	N/A	N/A	$1.54 per share	N/A
IXHL Incannex Healthcare	$90K	447.62	N/A	N/A	$2.07 per share	1.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGFY Agrify	-$41.75M	-$22.65	N/A	N/A	N/A	-424.11%	-185.90%	-72.67%	N/A
CALC CalciMedica	-$29.56M	-$6.80	N/A	N/A	N/A	N/A	N/A	-155.24%	11/11/2026 (Estimated)
FLNA Cassava Sciences	-$90.97M	-$0.87	N/A	N/A	N/A	N/A	-58.78%	-36.74%	N/A
IXHL Incannex Healthcare	-$19.30M	-$1.69	N/A	N/A	N/A	N/A	-25.62%	-24.46%	11/13/2026 (Estimated)

Latest CALC, FLNA, AGFY, and IXHL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/25/2026	Q4 2026	IXHL Incannex Healthcare	$0.13	-$0.14	-$0.27	-$0.15	$0.20 million	N/A
8/11/2026	Q2 2026	CALC CalciMedica	-$1.4250	-$0.45	+$0.9750	-$2.25	N/A	N/A
7/29/2026	Q2 2026	FLNA Cassava Sciences	N/A	-$0.18	N/A	-$0.18	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGFY Agrify	N/A	N/A	N/A	N/A	N/A
CALC CalciMedica	N/A	N/A	N/A	N/A	N/A
FLNA Cassava Sciences	N/A	N/A	N/A	N/A	N/A
IXHL Incannex Healthcare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGFY Agrify	1.43	2.64	2.52
CALC CalciMedica	1.67	5.58	5.58
FLNA Cassava Sciences	N/A	2.08	2.08
IXHL Incannex Healthcare	N/A	48.81	41.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGFY Agrify	5.98%
CALC CalciMedica	N/A
FLNA Cassava Sciences	38.05%
IXHL Incannex Healthcare	0.43%

Insider Ownership

Company	Insider Ownership
AGFY Agrify	2.16%
CALC CalciMedica	28.25%
FLNA Cassava Sciences	4.60%
IXHL Incannex Healthcare	1.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGFY Agrify	140	2.00 million	1.96 million	Not Optionable
CALC CalciMedica	15	6.83 million	4.90 million	No Data
FLNA Cassava Sciences	30	48.31 million	46.09 million	Optionable
IXHL Incannex Healthcare	12	12.55 million	12.38 million	Not Optionable

CALC, FLNA, AGFY, and IXHL Headlines

Recent News About These Companies

Incannex Healthcare (NASDAQ:IXHL) Stock Rating Lowered by Wall Street Zen

October 3 at 1:25 AM | americanbankingnews.com

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26

October 1 at 11:00 AM | newsfilecorp.comN

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26

October 1 at 10:54 AM | newsfilecorp.comN

Incannex Healthcare (NASDAQ:IXHL) Announces Quarterly Earnings Results

September 27, 2026 | americanbankingnews.com

Reviewing Talphera (NASDAQ:TLPH) & Incannex Healthcare (NASDAQ:IXHL)

September 27, 2026 | americanbankingnews.com

Scilex (NASDAQ:SCLX) versus Incannex Healthcare (NASDAQ:IXHL) Financial Survey

September 26, 2026 | americanbankingnews.com

Incannex Healthcare Inc. Reports Earnings Results for the Full Year Ended June 30, 2026

September 25, 2026 | marketscreener.comM

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

September 9, 2026 | globenewswire.com

Incannex Healthcare Doses First Patient in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

August 25, 2026 | quiverquant.comQ

Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X

August 25, 2026 | globenewswire.com

Incannex Healthcare Inc.

August 15, 2026 | cnn.com

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026

August 11, 2026 | finance.yahoo.com

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

July 23, 2026 | globenewswire.com

Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X

July 15, 2026 | finance.yahoo.com

Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea

June 26, 2026 | finanznachrichten.de

Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea

June 25, 2026 | globenewswire.com

Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility

June 10, 2026 | finanznachrichten.de

Incannex Healthcare Secures Over A$11 Million in Non-Dilutive Capital Through Australian R&D Tax Incentive Program

June 10, 2026 | quiverquant.comQ

Incannex Healthcare Secures Major Non-Dilutive R&D Funding

June 10, 2026 | tipranks.com

Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility

June 10, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CALC, FLNA, AGFY, and IXHL Company Descriptions

Agrify NASDAQ:AGFY

$19.60 -0.40 (-2.00%)

As of 10/2/2026

Agrify Corporation offers hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. It offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. The company also provides associated services comprising consulting, engineering, and construction. In addition, the company offers hydrocarbon, alcohol, solventless, post-processing, and lab equipment, as well as provides indoor farming solutions. In addition, it offers equipment and services in a contract and purchase order. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Troy, Michigan.

CalciMedica NASDAQ:CALC

$1.60 -0.05 (-3.03%)

Closing price 10/2/2026 03:56 PM Eastern

Extended Trading

$1.71 +0.11 (+6.81%)

As of 10/2/2026 07:51 PM Eastern

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops CM6336, an oral CRAC channel inhibitors for chronic inflammatory indications; and Auxora, for the treatment of acute ulcerative colitis and allergic asthma. The company is based in La Jolla, California.

Cassava Sciences NASDAQ:FLNA

$0.93 -0.03 (-3.53%)

As of 10/2/2026 04:00 PM Eastern

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Incannex Healthcare NASDAQ:IXHL

$3.21 -0.04 (-1.23%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$3.22 +0.01 (+0.34%)

As of 10/2/2026 07:58 PM Eastern

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications. The company offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. It also develops IHL-42X, which has completed Phase IIb clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 skin that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury and concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, suppoCan gastro for IBD, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. Incannex Healthcare Inc. was incorporated in 2001 and is based in Sydney, Australia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CALC, FLNA, AGFY, and IXHL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CALC, FLNA, AGFY, and IXHL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CALC, FLNA, AGFY, and IXHL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CALC, FLNA, AGFY, and IXHL Company Descriptions

Agrify NASDAQ:AGFY

CalciMedica NASDAQ:CALC

Cassava Sciences NASDAQ:FLNA

Incannex Healthcare NASDAQ:IXHL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CALC, FLNA, AGFY, and IXHL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CALC, FLNA, AGFY, and IXHL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CALC, FLNA, AGFY, and IXHL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CALC, FLNA, AGFY, and IXHL Company Descriptions

Agrify NASDAQ:AGFY

CalciMedica NASDAQ:CALC

Cassava Sciences NASDAQ:FLNA

Incannex Healthcare NASDAQ:IXHL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools